Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Return on Sales (2016 - 2025)

Historic Return on Sales for Gsk (GLAXF) over the last 17 years, with Q4 2025 value amounting to 0.3%.

  • Gsk's Return on Sales rose 800.0% to 0.3% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.3%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.36% for FY2022, which is 3000.0% up from last year.
  • According to the latest figures from Q4 2025, Gsk's Return on Sales is 0.3%, which was up 800.0% from 0.32% recorded in Q3 2025.
  • Over the past 5 years, Gsk's Return on Sales peaked at 1.29% during Q3 2022, and registered a low of 0.01% during Q3 2024.
  • In the last 5 years, Gsk's Return on Sales had a median value of 0.22% in 2024 and averaged 0.24%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 12200bps in 2022, then crashed by -10400bps in 2023.
  • Over the past 5 years, Gsk's Return on Sales (Quarter) stood at 0.07% in 2021, then crashed by -39bps to 0.04% in 2022, then surged by 643bps to 0.33% in 2023, then tumbled by -33bps to 0.22% in 2024, then skyrocketed by 38bps to 0.3% in 2025.
  • Its last three reported values are 0.3% in Q4 2025, 0.32% for Q3 2025, and 0.27% during Q2 2025.